Brain Sciences Webinar | World Mental Health Day 2022
10 Oct 2022, 10:00 (CEST)
Depression, autism spectrum disorderASD, Psychopharmacology, Neurodegeneration, Neuronal structure, Dopamine
- Event Details
Welcome
Brain Sciences Webinar
World Mental Health Day 2022
Whilst the pandemic has, and continues to, take its toll on our mental health, the ability to reconnect through World Mental Health Day 2022 will provide us with an opportunity to re-kindle our efforts to protect and improve mental health.
Many aspects of mental health have been challenged; and already before the pandemic in 2019 an estimated one in eight people globally were living with a mental disorder. At the same time, the services, skills and funding available for mental health remain in short supply, and fall far below what is needed, especially in low and middle income countries.
The COVID-19 pandemic has created a global crisis for mental health, fueling short- and long-term stresses and undermining the mental health of millions. Estimates put the rise in both anxiety and depressive disorders at more than 25% during the first year of the pandemic. At the same time, mental health services have been severely disrupted and the treatment gap for mental health conditions has widened.
Date: 10 October 2022
Webinar Secretariat: brainsciences.webinar@mdpi.com
Invited Speakers
Monash Alfred Psychiatry research centre, Monash University, Australia
Caroline Gurvich is a Clinical Neuropsychologist and an Associate Professor at Monash University, Melbourne Australia. She is the Deputy Director of HER Centre Australia, where she leads the Cognition and Hormones research group. Her research focuses on hormonal influences on cognition and their interactions with psychological and lifestyle factors, such as stress and early life trauma. She has over 100 publications that have ultimately contributed to a better understanding of neuropsychology in women’s mental health.
Psychobiology and Pediatric and Behavioral Neuroscience, University of Modena, Italy
Dr. Johanna MC Blom, Associate Professor in Psychobiology and Pediatric and Behavioral Neuroscience, University of Modena; Co-coordinator of the Horizon 2020 Framework Programme Innovative Medicine Initiative Grant IMI2-2020-23-01 "Returning Clinical Trial Data to study participants within a GDPR compliant and approved ethical framework” and partner of the EU project 101005642 — ECLIPS project to prevent and combat all forms of violence against children, young people and women. Chair of the Ethics Committee on Research using human subjects of the University of Modena and Reggio Emilia; Coordinator of the long-term follow-up of children with cancer and the use of psychotropic drugs, AIEOP; Member of PANCARE, SIOP, and the International Guideline Harmonization Group (IGHG) for the development of Psychosocial and Neurocognitive surveillance guidelines for survivors of childhood cancer. Expert in multidisciplinary behavioral toxicity studies and mental health in children and adolescents. Her current interests lie in (digital) assessment tools to detect early signs of cognitive and behavioral problems in youth and designing decision tree algorithms by using network analysis and dynamic mapping to understand the driving factors of the trajectory that moves a child or adolescent from being at risk to full blown pathology and test the effectiveness of treatment by linking them to outcome values dynamically recorded in an ecologically valid way.
Associate Clinician and Adjunct Professor at the Division of Child and Adolescent Neuropsychiatry, University General Hospital of Siena. Clinical and research activities are being in the field of Autism Spectrum Disorders (ASD) with a wide coverage of the field as to assessment, diagnosis and treatment. Clinical trials with experimental treatment in ASD are the area of active involvement and major commitment. Current study is in the recruitment stage with a serotoninergic agent to control irritability.
Prof. (apl) of Neurosciences and Biomedical Engineering, Westphalian Wilhelms University Germany Münster, Germany. Since12/2008 Head of the working group SIM-NEURO (“Stimulation, Imaging and Modeling of NEUROnal networks in the human brain”)
Dr. Marco Colizzi is an Assistant Professor of Psychiatry at the University of Udine, Italy. He qualified in Medicine from the University of Bari, Italy, in 2009. He completed his residency in Psychiatry, from the University of Bari, in 2015. He received a PhD in Neuroscience from the King’s College London, United Kingdom, in 2018, where he then became a Clinical Research Fellow and, after returning to Italy, a Visiting Researcher. Between 2019 and 2021, he worked as Clinical Research Fellow at the University of Verona, Italy, and, starting from December 2021, as Assistant Professor at the University of Udine. Dr. Colizzi’s research focuses on the neuropsychopharmacology and neurocognitive function of psychosis and neurodevelopmental conditions, with a focus on prevention and early intervention strategies in mental health. He has published a significant number of scientific articles in refereed international journals. He has received several awards and recognition by a number of prestigious national and international institutions.
Saarland University Hospital and Medical Faculty of Saarland University, Germany
Prof. Dr. Eva Möhler is Chair of Child and Adolescent Psychiatry and Psychotherapy, Saarland University Medical Center. Research interests: Early Life Stress, prenatal stress, child abuse and neglect, intergenerational transmission of abuse, adverse childhood experiences.
• Royal College of Physicians and Surgeons of Canada grant for continuing education (2014) • Mental Health Program Quality Council Certificate of Excellence Award for commitment to quality review (2012) • Mental Health Program Quality Council Certificate of Excellence Award for development and implementation of suicide risk assessment form (2012)
Department of Psychiatry, New York University Langone Medical Center, USA
Dr. Raj Balapal received his Ph.D. from Mysore University in Biochemistry in 1994. His postdoctoral training was at the Columbia University Medical Center and NYSPI prior to beginning as a Research Scientist at the Nathan Kline Institute in 2000. His research uses a mouse model of Fetal Alcohol Spectrum Disorders (FASDs) to investigate the impact of alcohol exposure during early development on synaptic plasticity and learning and memory behavior and the underlying cannabinoid receptor mediated signaling changes in hippocampus. His recent publications have showed that there are changes in anandamide, their metabolism, CB1 receptor signaling leading to neurodegeneration in neonatal brain neocortex and hippocampus.
Departments of Family Medicine and Urban Public Health, Charles R Drew University of Medicine and Science, Los Angeles, CA, USA
Dr. Shervin Assari is an associate professor of family medicine at Charles R. Drew University of Medicine and Science, Los Angeles. His interest is on the intersection of race, ethnicity, gender, and place in changing causes and consequences of health. Dr. Assari has published more than 350 papers on topics such as race, social determinants, and health equity.
Hershey Medical Center, Department of Psychiatry, Penn State University School of Medicine, Hershey, PA 17033, USA
Dr. Alfredo Bellon's current research involves transdifferentiation of human blood circulating monocytes into neuronal-like cells. He is using this model to study how the structure of neuronal-like cells from patients with schizophrenia responds to dopamine, ketamine and other compounds and neurotransmitters.
The Johns Hopkins University School of Medicine, Baltimore, MD, USA
James Robert Brasic is an assistant professor in the Section of High Resolution Brain Positron Emission Tomography Imaging of the Division of Nuclear Medicine and Molecular Imaging of the the Russell H. Morgan Department of Radiology and Radiological Science at the School of Medicine of The Johns Hopkins University in Baltimore, Maryland. James conducts research in molecular imaging of nervous and mental disorders. He welcomes opportunities to collaborate with colleagues around the world.
Program
Date: 10 October 2022
Time: 10:00 am CEST | 04:00 am EDT | 04:00 pm CST Asia
Webinar ID: 824 0459 3802
Speaker/Presentation |
Time in CEST |
Dr. Caroline Gurvich The Female Brain and Women’s Mental Health |
10:00 - 10:25 am |
Dr. Johanna Blom Mind Child and Adolescent Mental Health: Let's get involved! |
10:25 - 10:50 am |
Q&A |
10:50 - 11:00 am |
Date: 10 October 2022
Time: 01:00 pm CEST | 07:00 am EDT | 07:00 pm CST Asia
Webinar ID: 890 2598 2964
Speaker/Presentation |
Time in CEST |
Dr. Roberto Canitano Autism with Epilepsy a European Study |
01:00 - 01:25 pm |
Dr. Carsten Wolters Contribution of EEG, MEG and TES on Diagnosis and Therapy of Focal Epilepsy |
01:25 - 01:50 pm |
Dr. Marco Colizzi Evaluating the Mental Health Effects of COVID-19 Through the Biopsychosocial Model Framework |
01:50 - 02:15 pm |
Prof. Dr. Eva Möhler Stressful Times and Stress Resilience in Children and Adolescents |
02:15 - 02:40 pm |
Q&A |
02:40 - 03:00 pm |
Date: 10 October 2022
Time: 04:00 pm CEST | 10:00 am EDT | 10:00 pm CST Asia
Webinar ID: 830 6138 7138
Speaker/Presentation |
Time in CEST |
Dr. Balapal S. Basavarajappa Introduction |
04:00 - 04:05 pm |
Dr. Joseph Sadek Malingering and Stimulant Medications Abuse, Misuse and Diversion |
04:05 - 04:25 pm |
Dr. Shervin Assari Unequal Youth Brain Development in Middle-Class Families under Structural Racism, Social Stratification, and Residential Segregation |
04:25 - 04:45 pm |
Dr. James Robert Brasic Time Breathed Is Well Spent: a Relaxation Response to Cope with Stress |
04:45 - 05:05 pm |
Dr. Balapal S. Basavarajappa CDK5 in the Pathogenesis of FASD-like Phenotypes |
05:05 - 05:25 pm |
Dr. Alfredo Bellon Transdifferentiation of Human Monocytes and other Cellular Approaches to Mental Illnesses |
05:25 - 05:45 pm |
Q&A |
05:45 - 06:05 pm |